Oligodendroglioma clinical trials

Explore recruiting oligodendroglioma clinical trials.

Recruiting oligodendroglioma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Oligodendroglioma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

The ALPINE trial: a phase 1-2 study of intra-arterial [177Lu]Lu-PSMA-I&T for progressive or recurrent intracranial adult type diffuse glioma

Netherlands, Norway

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

A Phase 1 Single Center Clinical Trial Evaluating Safety of 5-Aminolevulinic Acid (5-ALA) Combined With CV01 Delivery of Ultrasound for Sonodynamic Therapy (SDT) in Patients With Newly Diagnosed High-Grade Glioma (HGG) Prior to Resection and Standard Adjuvant Therapy

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-Controlled Study of AG-881 in Subjects With Residual or Recurrent Grade 2 Glioma With an IDH1 or IDH2 Mutation

Germany, France, Italy, Spain, Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

Oligodendroglioma trials by city

Oligodendroglioma in Toronto Oligodendroglioma in Vancouver Oligodendroglioma in Montreal Oligodendroglioma in Calgary Oligodendroglioma in Edmonton Oligodendroglioma in Ottawa Oligodendroglioma in Winnipeg Oligodendroglioma in Quebec City Oligodendroglioma in Hamilton Oligodendroglioma in Kitchener Oligodendroglioma in London Oligodendroglioma in Halifax Oligodendroglioma in New York Oligodendroglioma in Los Angeles Oligodendroglioma in Chicago Oligodendroglioma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease